Global Parkinsons Disease Drug Market Growth 2024-2031

Report ID: 1330963 | Published Date: Jan 2025 | No. of Page: 104 | Base Year: 2024 | Rating: 4.4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Parkinsons Disease Drug Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Parkinsons Disease Drug by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Parkinsons Disease Drug by Country/Region, 2017, 2022 & 2028
    2.2 Parkinsons Disease Drug Segment by Type
        2.2.1 Carbidopa/Levodopa
        2.2.2 Dopamine Receptor Agonists
        2.2.3 MAO-Inhibitors
    2.3 Parkinsons Disease Drug Sales by Type
        2.3.1 Global Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
        2.3.2 Global Parkinsons Disease Drug Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Parkinsons Disease Drug Sale Price by Type (2017-2022)
    2.4 Parkinsons Disease Drug Segment by Application
        2.4.1 Hospital
        2.4.2 Clinics
        2.4.3 Other
    2.5 Parkinsons Disease Drug Sales by Application
        2.5.1 Global Parkinsons Disease Drug Sale Market Share by Application (2017-2022)
        2.5.2 Global Parkinsons Disease Drug Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Parkinsons Disease Drug Sale Price by Application (2017-2022)
3 Global Parkinsons Disease Drug by Company
    3.1 Global Parkinsons Disease Drug Breakdown Data by Company
        3.1.1 Global Parkinsons Disease Drug Annual Sales by Company (2020-2022)
        3.1.2 Global Parkinsons Disease Drug Sales Market Share by Company (2020-2022)
    3.2 Global Parkinsons Disease Drug Annual Revenue by Company (2020-2022)
        3.2.1 Global Parkinsons Disease Drug Revenue by Company (2020-2022)
        3.2.2 Global Parkinsons Disease Drug Revenue Market Share by Company (2020-2022)
    3.3 Global Parkinsons Disease Drug Sale Price by Company
    3.4 Key Manufacturers Parkinsons Disease Drug Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Parkinsons Disease Drug Product Location Distribution
        3.4.2 Players Parkinsons Disease Drug Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Parkinsons Disease Drug by Geographic Region
    4.1 World Historic Parkinsons Disease Drug Market Size by Geographic Region (2017-2022)
        4.1.1 Global Parkinsons Disease Drug Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Parkinsons Disease Drug Annual Revenue by Geographic Region
    4.2 World Historic Parkinsons Disease Drug Market Size by Country/Region (2017-2022)
        4.2.1 Global Parkinsons Disease Drug Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Parkinsons Disease Drug Annual Revenue by Country/Region
    4.3 Americas Parkinsons Disease Drug Sales Growth
    4.4 APAC Parkinsons Disease Drug Sales Growth
    4.5 Europe Parkinsons Disease Drug Sales Growth
    4.6 Middle East & Africa Parkinsons Disease Drug Sales Growth
5 Americas
    5.1 Americas Parkinsons Disease Drug Sales by Country
        5.1.1 Americas Parkinsons Disease Drug Sales by Country (2017-2022)
        5.1.2 Americas Parkinsons Disease Drug Revenue by Country (2017-2022)
    5.2 Americas Parkinsons Disease Drug Sales by Type
    5.3 Americas Parkinsons Disease Drug Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Parkinsons Disease Drug Sales by Region
        6.1.1 APAC Parkinsons Disease Drug Sales by Region (2017-2022)
        6.1.2 APAC Parkinsons Disease Drug Revenue by Region (2017-2022)
    6.2 APAC Parkinsons Disease Drug Sales by Type
    6.3 APAC Parkinsons Disease Drug Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Parkinsons Disease Drug by Country
        7.1.1 Europe Parkinsons Disease Drug Sales by Country (2017-2022)
        7.1.2 Europe Parkinsons Disease Drug Revenue by Country (2017-2022)
    7.2 Europe Parkinsons Disease Drug Sales by Type
    7.3 Europe Parkinsons Disease Drug Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Parkinsons Disease Drug by Country
        8.1.1 Middle East & Africa Parkinsons Disease Drug Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2022)
    8.2 Middle East & Africa Parkinsons Disease Drug Sales by Type
    8.3 Middle East & Africa Parkinsons Disease Drug Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Parkinsons Disease Drug
    10.3 Manufacturing Process Analysis of Parkinsons Disease Drug
    10.4 Industry Chain Structure of Parkinsons Disease Drug
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Parkinsons Disease Drug Distributors
    11.3 Parkinsons Disease Drug Customer
12 World Forecast Review for Parkinsons Disease Drug by Geographic Region
    12.1 Global Parkinsons Disease Drug Market Size Forecast by Region
        12.1.1 Global Parkinsons Disease Drug Forecast by Region (2023-2028)
        12.1.2 Global Parkinsons Disease Drug Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Parkinsons Disease Drug Forecast by Type
    12.7 Global Parkinsons Disease Drug Forecast by Application
13 Key Players Analysis
    13.1 Teva
        13.1.1 Teva Company Information
        13.1.2 Teva Parkinsons Disease Drug Product Offered
        13.1.3 Teva Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Teva Main Business Overview
        13.1.5 Teva Latest Developments
    13.2 Novartis AG
        13.2.1 Novartis AG Company Information
        13.2.2 Novartis AG Parkinsons Disease Drug Product Offered
        13.2.3 Novartis AG Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 Novartis AG Main Business Overview
        13.2.5 Novartis AG Latest Developments
    13.3 GSK
        13.3.1 GSK Company Information
        13.3.2 GSK Parkinsons Disease Drug Product Offered
        13.3.3 GSK Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 GSK Main Business Overview
        13.3.5 GSK Latest Developments
    13.4 AbbVie
        13.4.1 AbbVie Company Information
        13.4.2 AbbVie Parkinsons Disease Drug Product Offered
        13.4.3 AbbVie Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 AbbVie Main Business Overview
        13.4.5 AbbVie Latest Developments
    13.5 Merck
        13.5.1 Merck Company Information
        13.5.2 Merck Parkinsons Disease Drug Product Offered
        13.5.3 Merck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Merck Main Business Overview
        13.5.5 Merck Latest Developments
    13.6 Boehringer Ingelheim
        13.6.1 Boehringer Ingelheim Company Information
        13.6.2 Boehringer Ingelheim Parkinsons Disease Drug Product Offered
        13.6.3 Boehringer Ingelheim Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Boehringer Ingelheim Main Business Overview
        13.6.5 Boehringer Ingelheim Latest Developments
    13.7 Impax Laboratories
        13.7.1 Impax Laboratories Company Information
        13.7.2 Impax Laboratories Parkinsons Disease Drug Product Offered
        13.7.3 Impax Laboratories Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Impax Laboratories Main Business Overview
        13.7.5 Impax Laboratories Latest Developments
    13.8 Lundbeck
        13.8.1 Lundbeck Company Information
        13.8.2 Lundbeck Parkinsons Disease Drug Product Offered
        13.8.3 Lundbeck Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Lundbeck Main Business Overview
        13.8.5 Lundbeck Latest Developments
    13.9 Sun Pharma
        13.9.1 Sun Pharma Company Information
        13.9.2 Sun Pharma Parkinsons Disease Drug Product Offered
        13.9.3 Sun Pharma Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 Sun Pharma Main Business Overview
        13.9.5 Sun Pharma Latest Developments
    13.10 Wockhardt
        13.10.1 Wockhardt Company Information
        13.10.2 Wockhardt Parkinsons Disease Drug Product Offered
        13.10.3 Wockhardt Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 Wockhardt Main Business Overview
        13.10.5 Wockhardt Latest Developments
    13.11 UCB
        13.11.1 UCB Company Information
        13.11.2 UCB Parkinsons Disease Drug Product Offered
        13.11.3 UCB Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 UCB Main Business Overview
        13.11.5 UCB Latest Developments
    13.12 Bausch Health
        13.12.1 Bausch Health Company Information
        13.12.2 Bausch Health Parkinsons Disease Drug Product Offered
        13.12.3 Bausch Health Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Bausch Health Main Business Overview
        13.12.5 Bausch Health Latest Developments
    13.13 Acadia
        13.13.1 Acadia Company Information
        13.13.2 Acadia Parkinsons Disease Drug Product Offered
        13.13.3 Acadia Parkinsons Disease Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Acadia Main Business Overview
        13.13.5 Acadia Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Parkinsons Disease Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Parkinsons Disease Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of Carbidopa/Levodopa
    Table 4. Major Players of Dopamine Receptor Agonists
    Table 5. Major Players of MAO-Inhibitors
    Table 6. Global Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 7. Global Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
    Table 8. Global Parkinsons Disease Drug Revenue by Type (2017-2022) & ($ million)
    Table 9. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2022)
    Table 10. Global Parkinsons Disease Drug Sale Price by Type (2017-2022) & (USD/Dose)
    Table 11. Global Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 12. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Table 13. Global Parkinsons Disease Drug Revenue by Application (2017-2022)
    Table 14. Global Parkinsons Disease Drug Revenue Market Share by Application (2017-2022)
    Table 15. Global Parkinsons Disease Drug Sale Price by Application (2017-2022) & (USD/Dose)
    Table 16. Global Parkinsons Disease Drug Sales by Company (2020-2022) & (K Doses)
    Table 17. Global Parkinsons Disease Drug Sales Market Share by Company (2020-2022)
    Table 18. Global Parkinsons Disease Drug Revenue by Company (2020-2022) ($ Millions)
    Table 19. Global Parkinsons Disease Drug Revenue Market Share by Company (2020-2022)
    Table 20. Global Parkinsons Disease Drug Sale Price by Company (2020-2022) & (USD/Dose)
    Table 21. Key Manufacturers Parkinsons Disease Drug Producing Area Distribution and Sales Area
    Table 22. Players Parkinsons Disease Drug Products Offered
    Table 23. Parkinsons Disease Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 24. New Products and Potential Entrants
    Table 25. Mergers & Acquisitions, Expansion
    Table 26. Global Parkinsons Disease Drug Sales by Geographic Region (2017-2022) & (K Doses)
    Table 27. Global Parkinsons Disease Drug Sales Market Share Geographic Region (2017-2022)
    Table 28. Global Parkinsons Disease Drug Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 29. Global Parkinsons Disease Drug Revenue Market Share by Geographic Region (2017-2022)
    Table 30. Global Parkinsons Disease Drug Sales by Country/Region (2017-2022) & (K Doses)
    Table 31. Global Parkinsons Disease Drug Sales Market Share by Country/Region (2017-2022)
    Table 32. Global Parkinsons Disease Drug Revenue by Country/Region (2017-2022) & ($ millions)
    Table 33. Global Parkinsons Disease Drug Revenue Market Share by Country/Region (2017-2022)
    Table 34. Americas Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 35. Americas Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
    Table 36. Americas Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 37. Americas Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
    Table 38. Americas Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 39. Americas Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
    Table 40. Americas Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 41. Americas Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Table 42. APAC Parkinsons Disease Drug Sales by Region (2017-2022) & (K Doses)
    Table 43. APAC Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
    Table 44. APAC Parkinsons Disease Drug Revenue by Region (2017-2022) & ($ Millions)
    Table 45. APAC Parkinsons Disease Drug Revenue Market Share by Region (2017-2022)
    Table 46. APAC Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 47. APAC Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
    Table 48. APAC Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 49. APAC Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Table 50. Europe Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 51. Europe Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
    Table 52. Europe Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 53. Europe Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
    Table 54. Europe Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 55. Europe Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
    Table 56. Europe Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 57. Europe Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Table 58. Middle East & Africa Parkinsons Disease Drug Sales by Country (2017-2022) & (K Doses)
    Table 59. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country (2017-2022)
    Table 60. Middle East & Africa Parkinsons Disease Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 61. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Parkinsons Disease Drug Sales by Type (2017-2022) & (K Doses)
    Table 63. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Type (2017-2022)
    Table 64. Middle East & Africa Parkinsons Disease Drug Sales by Application (2017-2022) & (K Doses)
    Table 65. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Table 66. Key Market Drivers & Growth Opportunities of Parkinsons Disease Drug
    Table 67. Key Market Challenges & Risks of Parkinsons Disease Drug
    Table 68. Key Industry Trends of Parkinsons Disease Drug
    Table 69. Parkinsons Disease Drug Raw Material
    Table 70. Key Suppliers of Raw Materials
    Table 71. Parkinsons Disease Drug Distributors List
    Table 72. Parkinsons Disease Drug Customer List
    Table 73. Global Parkinsons Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)
    Table 74. Global Parkinsons Disease Drug Sales Market Forecast by Region
    Table 75. Global Parkinsons Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 76. Global Parkinsons Disease Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 77. Americas Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
    Table 78. Americas Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 79. APAC Parkinsons Disease Drug Sales Forecast by Region (2023-2028) & (K Doses)
    Table 80. APAC Parkinsons Disease Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 81. Europe Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
    Table 82. Europe Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 83. Middle East & Africa Parkinsons Disease Drug Sales Forecast by Country (2023-2028) & (K Doses)
    Table 84. Middle East & Africa Parkinsons Disease Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Global Parkinsons Disease Drug Sales Forecast by Type (2023-2028) & (K Doses)
    Table 86. Global Parkinsons Disease Drug Sales Market Share Forecast by Type (2023-2028)
    Table 87. Global Parkinsons Disease Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 88. Global Parkinsons Disease Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 89. Global Parkinsons Disease Drug Sales Forecast by Application (2023-2028) & (K Doses)
    Table 90. Global Parkinsons Disease Drug Sales Market Share Forecast by Application (2023-2028)
    Table 91. Global Parkinsons Disease Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 92. Global Parkinsons Disease Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 93. Teva Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 94. Teva Parkinsons Disease Drug Product Offered
    Table 95. Teva Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 96. Teva Main Business
    Table 97. Teva Latest Developments
    Table 98. Novartis AG Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 99. Novartis AG Parkinsons Disease Drug Product Offered
    Table 100. Novartis AG Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 101. Novartis AG Main Business
    Table 102. Novartis AG Latest Developments
    Table 103. GSK Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 104. GSK Parkinsons Disease Drug Product Offered
    Table 105. GSK Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 106. GSK Main Business
    Table 107. GSK Latest Developments
    Table 108. AbbVie Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 109. AbbVie Parkinsons Disease Drug Product Offered
    Table 110. AbbVie Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 111. AbbVie Main Business
    Table 112. AbbVie Latest Developments
    Table 113. Merck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 114. Merck Parkinsons Disease Drug Product Offered
    Table 115. Merck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 116. Merck Main Business
    Table 117. Merck Latest Developments
    Table 118. Boehringer Ingelheim Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 119. Boehringer Ingelheim Parkinsons Disease Drug Product Offered
    Table 120. Boehringer Ingelheim Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 121. Boehringer Ingelheim Main Business
    Table 122. Boehringer Ingelheim Latest Developments
    Table 123. Impax Laboratories Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 124. Impax Laboratories Parkinsons Disease Drug Product Offered
    Table 125. Impax Laboratories Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 126. Impax Laboratories Main Business
    Table 127. Impax Laboratories Latest Developments
    Table 128. Lundbeck Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 129. Lundbeck Parkinsons Disease Drug Product Offered
    Table 130. Lundbeck Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 131. Lundbeck Main Business
    Table 132. Lundbeck Latest Developments
    Table 133. Sun Pharma Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 134. Sun Pharma Parkinsons Disease Drug Product Offered
    Table 135. Sun Pharma Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 136. Sun Pharma Main Business
    Table 137. Sun Pharma Latest Developments
    Table 138. Wockhardt Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 139. Wockhardt Parkinsons Disease Drug Product Offered
    Table 140. Wockhardt Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 141. Wockhardt Main Business
    Table 142. Wockhardt Latest Developments
    Table 143. UCB Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 144. UCB Parkinsons Disease Drug Product Offered
    Table 145. UCB Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 146. UCB Main Business
    Table 147. UCB Latest Developments
    Table 148. Bausch Health Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 149. Bausch Health Parkinsons Disease Drug Product Offered
    Table 150. Bausch Health Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 151. Bausch Health Main Business
    Table 152. Bausch Health Latest Developments
    Table 153. Acadia Basic Information, Parkinsons Disease Drug Manufacturing Base, Sales Area and Its Competitors
    Table 154. Acadia Parkinsons Disease Drug Product Offered
    Table 155. Acadia Parkinsons Disease Drug Sales (K Doses), Revenue ($ Million), Price (USD/Dose) and Gross Margin (2020-2022)
    Table 156. Acadia Main Business
    Table 157. Acadia Latest Developments
List of Figures
    Figure 1. Picture of Parkinsons Disease Drug
    Figure 2. Parkinsons Disease Drug Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Parkinsons Disease Drug Sales Growth Rate 2017-2028 (K Doses)
    Figure 7. Global Parkinsons Disease Drug Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Parkinsons Disease Drug Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of Carbidopa/Levodopa
    Figure 10. Product Picture of Dopamine Receptor Agonists
    Figure 11. Product Picture of MAO-Inhibitors
    Figure 12. Global Parkinsons Disease Drug Sales Market Share by Type in 2021
    Figure 13. Global Parkinsons Disease Drug Revenue Market Share by Type (2017-2022)
    Figure 14. Parkinsons Disease Drug Consumed in Hospital
    Figure 15. Global Parkinsons Disease Drug Market: Hospital (2017-2022) & (K Doses)
    Figure 16. Parkinsons Disease Drug Consumed in Clinics
    Figure 17. Global Parkinsons Disease Drug Market: Clinics (2017-2022) & (K Doses)
    Figure 18. Parkinsons Disease Drug Consumed in Other
    Figure 19. Global Parkinsons Disease Drug Market: Other (2017-2022) & (K Doses)
    Figure 20. Global Parkinsons Disease Drug Sales Market Share by Application (2017-2022)
    Figure 21. Global Parkinsons Disease Drug Revenue Market Share by Application in 2021
    Figure 22. Parkinsons Disease Drug Revenue Market by Company in 2021 ($ Million)
    Figure 23. Global Parkinsons Disease Drug Revenue Market Share by Company in 2021
    Figure 24. Global Parkinsons Disease Drug Sales Market Share by Geographic Region (2017-2022)
    Figure 25. Global Parkinsons Disease Drug Revenue Market Share by Geographic Region in 2021
    Figure 26. Global Parkinsons Disease Drug Sales Market Share by Region (2017-2022)
    Figure 27. Global Parkinsons Disease Drug Revenue Market Share by Country/Region in 2021
    Figure 28. Americas Parkinsons Disease Drug Sales 2017-2022 (K Doses)
    Figure 29. Americas Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
    Figure 30. APAC Parkinsons Disease Drug Sales 2017-2022 (K Doses)
    Figure 31. APAC Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
    Figure 32. Europe Parkinsons Disease Drug Sales 2017-2022 (K Doses)
    Figure 33. Europe Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
    Figure 34. Middle East & Africa Parkinsons Disease Drug Sales 2017-2022 (K Doses)
    Figure 35. Middle East & Africa Parkinsons Disease Drug Revenue 2017-2022 ($ Millions)
    Figure 36. Americas Parkinsons Disease Drug Sales Market Share by Country in 2021
    Figure 37. Americas Parkinsons Disease Drug Revenue Market Share by Country in 2021
    Figure 38. United States Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 39. Canada Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 40. Mexico Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Brazil Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 42. APAC Parkinsons Disease Drug Sales Market Share by Region in 2021
    Figure 43. APAC Parkinsons Disease Drug Revenue Market Share by Regions in 2021
    Figure 44. China Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 45. Japan Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 46. South Korea Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Southeast Asia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 48. India Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Australia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 50. Europe Parkinsons Disease Drug Sales Market Share by Country in 2021
    Figure 51. Europe Parkinsons Disease Drug Revenue Market Share by Country in 2021
    Figure 52. Germany Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 53. France Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 54. UK Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 55. Italy Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 56. Russia Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Middle East & Africa Parkinsons Disease Drug Sales Market Share by Country in 2021
    Figure 58. Middle East & Africa Parkinsons Disease Drug Revenue Market Share by Country in 2021
    Figure 59. Egypt Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 60. South Africa Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 61. Israel Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 62. Turkey Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 63. GCC Country Parkinsons Disease Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Manufacturing Cost Structure Analysis of Parkinsons Disease Drug in 2021
    Figure 65. Manufacturing Process Analysis of Parkinsons Disease Drug
    Figure 66. Industry Chain Structure of Parkinsons Disease Drug
    Figure 67. Channels of Distribution
    Figure 68. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Parkinsons Disease Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Parkinsons Disease Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Parkinsons Disease Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports